| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.012 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0055 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0054 | 1 |